PARP-INHIBITORS ROLE IN THE TREATMENT OF OVARIAN CANCER

被引:0
|
作者
Mahon, Lauren [1 ]
机构
[1] Univ Rochester, Rochester, NY USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1
引用
收藏
页数:1
相关论文
共 50 条
  • [21] PI3K-and PARP-inhibitors for the treatment of women cancers
    Wulf, Gerburg M.
    Juvekar, Ashish
    Cantley, Lewis C.
    Matulonis, Ursula A.
    CLINICAL CANCER RESEARCH, 2016, 22
  • [22] Bevacizumab versus PARP-inhibitors in women with newly diagnosed ovarian cancer: a network meta-analysis
    Suh, Young Ju
    Lee, Banghyun
    Kim, Kidong
    Jeong, Yujin
    Choi, Hwa Yeon
    Hwang, Sung Ook
    Kim, Yong Beom
    BMC CANCER, 2022, 22 (01)
  • [23] Using PARP Inhibitors in the Treatment of Patients With Ovarian Cancer
    Kurnit, Katherine C.
    Coleman, Robert L.
    Westin, Shannon N.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (12)
  • [24] What Is the Place of PARP Inhibitors in Ovarian Cancer Treatment?
    Joyce F. Liu
    Ursula A. Matulonis
    Current Oncology Reports, 2016, 18
  • [25] Using PARP Inhibitors in the Treatment of Patients With Ovarian Cancer
    Katherine C. Kurnit
    Robert L. Coleman
    Shannon N. Westin
    Current Treatment Options in Oncology, 2018, 19
  • [26] Advances in Ovarian Cancer Treatment Beyond PARP Inhibitors
    Aliyuda, Fine
    Moschetta, Michele
    Ghose, Aruni
    Rallis, Kathrine Sofia
    Sheriff, Matin
    Sanchez, Elisabet
    Rassy, Elie
    Boussios, Stergios
    CURRENT CANCER DRUG TARGETS, 2023, 23 (06) : 433 - 446
  • [27] What Is the Place of PARP Inhibitors in Ovarian Cancer Treatment?
    Liu, Joyce F.
    Matulonis, Ursula A.
    CURRENT ONCOLOGY REPORTS, 2016, 18 (05)
  • [28] PARP INHIBITORS AS FRONTLINE TREATMENT IN PATIENTS WITH OVARIAN CANCER
    Wright, Kevin
    ONCOLOGY-NEW YORK, 2020, 34 (03): : 86 - 86
  • [29] PARP Inhibitors in Ovarian Cancer
    Mittica, Gloria
    Ghisoni, Eleonora
    Giannone, Gaia
    Genta, Sofia
    Aglietta, Massimo
    Sapino, Anna
    Valabrega, Giorgio
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2018, 13 (04) : 392 - 410
  • [30] PARP inhibitors in ovarian cancer
    David Cibula
    Judith Balmaña
    British Journal of Cancer, 2015, 113 : S1 - S2